Breathing new life into mature medicines

Our purpose, our mission and our principles

The preferred acquirer for large cap or speciality pharma businesses choosing to divest

We want to be the preferred acquirer for large cap or speciality pharma businesses choosing to divest choosing to divest their "mature", 'established" or "tail" off-patent branded medicines. We recognise that they may have different reasons for choosing to divest, and will have different requirements at different stages of the sale process. We understand these requirements intrinsically and believe we are uniquely positioned to meet them.

1

Pre-completion

We can arrive at and make an offer quickly. We will consider acquisitions of individual medicines or markets, or bundles of medicines or markets globally. We have a simple capital structure enabling us to complete acquisitions rapidly.

2

During transition

We are an efficient and experienced transaction counterparty. We have a tried-and-tested transition methodology.

3

Post-transition

We are a trusted and diligent caretaker of the brand. We have built a platform that can absorb and manage on an ongoing basis new acquisitions seamlessly.

Looking to license or divest a medicine?

Or are you a CMO or distributor who wishes to partner with us?

Get in touch